Early in female mammalian embryonic development, cells randomly inactivate one of the two X chromosomes to achieve overall equal inactivation of parental X-linked alleles. Hcfc1 is a highly conserved X-linked mouse gene that encodes HCF-1 -a transcriptional co-regulator implicated in cell proliferation in tissue culture cells. By generating a Cre-recombinase inducible Hcfc1 knock-out (Hcfc1 lox ) allele in mice, we have probed the role of HCF-1 in actively proliferating embryonic cells and in cell-cycle re-entry of resting differentiated adult cells using a liver regeneration model. HCF-1 function is required for both extraembryonic and embryonic development. In heterozygous Hcfc1 lox/ þ female embryos, however, embryonic epiblast-specific Cre-induced Hcfc1 deletion (creating an Hcfc1 epiKO allele) around E5.5 is well tolerated; it leads to a mixture of HCF-1-positive and -negative epiblast cells owing to random X-chromosome inactivation of the wild-type or Hcfc1 epiKO mutant allele. At E6.5 and E7.5, both HCF-1-positive and -negative epiblast cells proliferate, but gradually by E8.5, HCF-1-negative cells disappear owing to cell-cycle exit and apoptosis. Although generating a temporary developmental retardation, the loss of HCF-1-negative cells is tolerated, leading to viable heterozygous offspring with 100% skewed inactivation of the X-linked Hcfc1 epiKO allele. In resting adult liver cells, the requirement for HCF-1 in cell proliferation was more evident as hepatocytes lacking HCF-1 fail to re-enter the cell cycle and thus to proliferate during liver regeneration. The survival of the heterozygous Hcfc1 epiKO/ þ female embryos, even with half the cells genetically compromised, illustrates the developmental plasticity of the post-implantation mouse embryo -in this instance, permitting survival of females heterozygous for an X-linked embryonic lethal allele.
Introduction
During animal development a totipotent zygote becomes a differentiated multicellular organism through regulated patterns of cell proliferation and differentiation, which themselves are controlled via programs of gene transcription. Chromatin is the structural basis by which the genome is packaged and genes are transcriptionally regulated. Transcriptional regulation involves physical association between sequence-specific DNA-binding proteins and chromatin-modifying enzymes, which in some cases is aided by protein adaptors that physically link these two classes of regulators. An example of the latter class is the human herpes simplex virus host-cell factor HCF-1 (for reviews see Kristie et al. (2010) and Zargar and Tyagi (2012) ).
HCF-1 is a conserved metazoan protein. In mice and human, it resides at the transcriptional start sites of many genes (e.g., 743 in embryonal stem cells and over 5000 in HeLa cells; (Dejosez et al., 2010; Michaud et al., 2013) ) and associates with both sequencespecific DNA-binding proteins (e.g., E2F1 and E2F4, Thap11/Ronin, ZNF143) and chromatin-modifying enzymes (e.g., MLL and Set1 histone H3 Lysine 4 methyltransferases and Sin3 histone deacetylase) (for review see Zargar and Tyagi (2012) ). Genetic studies in mammalian cell culture have shown that HCF-1 is important for multiple aspects of cell proliferation Julien and Herr, 2003; . For example, temperaturesensitive tsBN67 cells, which carry a point mutation in the hamster gene encoding HCF-1, exit from the cell-division cycle in the G1 phase when transferred from 33.5°C to 40°C -but not immediately, rather after about two rounds of cell division .
Here, we study the cell proliferation and developmental roles of HCF-1 in mice. The mouse gene encoding HCF-1 is called Hcfc1 and resides on the X chromosome (Frattini et al., 1996; Kristie, 1997) , and as such is subject to transcriptional silencing via Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology X-chromosome inactivation. X-chromosome inactivation in female mammals occurs in two waves -imprinted followed by random inactivation: (i) in the imprinted form, soon after fertilization, there is exclusive inactivation of the paternally inherited X (Xp) chromosome such that only the maternally inherited X (Xm) chromosome is active in both embryonic and extraembryonic tissues; (ii) in the random form, the Xp chromosome is reactivated around the time of implantation in the embryonic tissue exclusively and either X chromosome is subsequently randomly inactivated (for reviews, see Augui et al. (2011) and Heard and Disteche (2006) ).
In heterozygous cells, random X-chromosome inactivation can be used to study the activity of wild-type and mutant alleles separately but in side-by-side cells. Here, we used this property, combined with the generation of a conditional mouse Hcfc1 knock-out allele (Hcfc1 cKO ), to study the role of HCF-1 in embryonic and extraembryonic as well as adult tissues. The results reveal essential but differing embryonic and adult roles of HCF-1 in cell proliferation. They illustrate as well high plasticity in postimplantation development as wild-type embryonic cells can fully compensate for the loss of proliferative potential in their HCF-1-negative cohorts.
Materials and methods

Mice
All experimental studies have been performed in compliance with the EU and national legislation rules, as advised by the Lemanique Animal Facility Network (Resal), concerning ethical considerations of transportation, housing, strain maintenance, breeding and experimental use of animals.
Mice bearing the Hcfc1 conditional (lox) allele were generated by Ozgene Pty Ltd. The targeting vector contained a 10 kb genomic sequence of part of the Hcfc1 gene and its upstream sequence. Briefly, an 870 bp PCR product containing Hcfc1 exons 2 and 3 and their flanking intron sequences was amplified from C57BL/6 genomic DNA and cloned into pPCR. The forward primer was designed to include a loxP site (5′ loxP) for Cre-induced recombination and the reverse primer a PacI site for subsequent cloning. A PGK-Neo-SD-IS cassette flanked by FRT sites containing a second loxP site (3′ loxP) at the 3′ end was inserted into the PacI site. For homologous recombination, a 5.2 kb fragment upstream of exon 2 was inserted before the 5′ loxP site and a 3.9 kb fragment downstream of exon 3 was inserted after the 3′ loxP site. With this construct a homologously recombined male C57BL/6 embryonicstem cell line was isolated and successfully used to create a mosaic mouse for successful germ-line transmission. The official name for the resulting mouse allele is B6-Hcfc1tm1
Lwh according to the guidelines by Mouse Genome Informatics (MGI, The Jackson Laboratory) but it is referred to here as Hcfc1 lox . The Hcfc1 lox allele contains two loxP sites, one in intron 1 and another in intron 3, and can undergo recombination in the presence of Cre recombinase. Cre-recombinase-induced deletion of exons 2 and 3 resulted in splicing of exons 1 and 4 as determined by RNA-sequence analysis (see tamoxifen induction below).
Other strains used in this study include wild-type C57BL/6 mice and C57BL/6 mice carrying the Sox2Cre tg (Hayashi et al., 2002) , CAG-EGFP tg (Hadjantonakis et al., 1998) , and Alb-Cre-ERT2 tg ( (Schuler et al., 2004) ; a gift from Dr. Daniel Metzger, IGBMC Strasbourg) transgenes. Females and littermate males were housed four to five per cage at 23°C, with a 12:12 h light-dark cycle and ad libitum access to water and food.
DNA isolation and genotyping
For genotyping, genomic DNA was isolated from mouse ear tags for postnatal mice or entire conceptus for whole embryos as previously described (Truett et al., 2000) . For paraffin-embedded embryo sections, DNA for genotyping was extracted by (i) preferential scraping of the epiblast region of 3-4 sections with a surgical blade, (ii) transferring the scraped sections into an eppendorf tube, and (iii) deparaffinizing and xylene removal as described (Gohar and Mohammadi, 2009 ). Subsequent DNA extraction was done as described (Truett et al., 2000) . Samples were used for PCR amplification with specific primer sets using the KAPA2G Fast HotStart Genotyping PCR Mix (cat no. KK5621). The annealing was done at 62°C for 15 s with an extension at 72°C for 10 s.
Primers for genotyping are listed below. For HCF-1: p1 (5′-GGAGGAACATGAGCTTTAGG-3′), p2 (5′-CAA-TAGGCGAGTACCATCACAC-3′), and p3 (5′-GGGAAAGTA-GACCCACTCTG-3′).
For Cre: Sense (5′-AGGTGTAGAGAAGGCACTTAGC-3′) and Antisense (5′-CTAATCGCCATCTTCCAGCAGG-3′) (Le and Sauer, 2000) .
For Y chromosome: Sry-1 (5′-AACAACTGGGCTTTGCACATTG-3′) and Sry-2 (5′-GTTTATCAGGGTTTCTCTCTAGC-3′) (Steele-Perkins et al., 2005) .
For GFP: oIMR0872 (5′-AAGTTCATCTGCACCACCG-3′) and oIMR1416 (5′-TCCTTGAAGAAGATGGTGCG-3′).
Tamoxifen induction
Control Hcfc1
lox/ þ and test Alb-Cre-ERT2 tg ; Hcfc1 lox/ þ adult mice (10-14 weeks old) were administered intraperitoneal injections of 1 mg/mouse tamoxifen [100 μl of 10 mg/ml (1:10 ethanol:
corn oil); Sigma-Aldrich CAS#10540-29-1] four times every 24 h starting on Day 0. High-throughput RNA-sequence analysis showed that the tamoxifen-induced hepatic Hcfc1 hepKO deletion in Alb-Cre-ERT2 tg ; Hcfc1 hepKO/ þ mice led to splicing of Hcfc1 exon 1 to exon 4.
BrdU incorporation
To label embryonic cells in S phase, pregnant mice were injected intraperitoneally with the cell-proliferation marker, 5-bromo-2′-deoxyuridine (BrdU; BD Biosciences, cat. # 550891) to a final concentration of 50 mg/kg body weight, sacrificed 6 h postinjection, and BrdU incorporation revealed by immunofluorescence staining (see below).
Tissue histology and immunohistochemistry
Intact embryonic day (E) 6.5 to E8.5 embryos were paraffinembedded and sectioned within their decidua along a sagittal axis to generate 4 μm thick sections using a microtome (MICROM HM325). Similarly, paraffin-embedded E12.5 embryos, and postnatal (P) 0 and P5 brain and liver tissue samples were also sliced at 4 μm thickness. Early postnatal and adult brain and liver samples were cut with the help of a cryostat microtome (MICROM HM550) to generate 20 μm thick cryo-sections.
Paraffin-embedded sections were (i) deparaffinized in xylene, (ii) rehydrated through graded alcohol washes, (iii) rinsed twice with PBS, (iv) antigen revealed by heating in a 750 W microwave oven until boiling (approximately 10 min) in citrate buffer (10 mM, pH 6.0), (v) allowed to slowly cool down at 4°C, (vi) washed twice with PBS, and (vii) blocked for 30 min with 2% normal goat serum (NGS) (Sigma-Aldrich, cat. #G9023) in PBS at room temperature (RT).
Cryo-sections were (i) dried for 10 min, (ii) fixed for 10 min with 4% paraformaldehyde (Electron Microscopy Sciences, CAS #30525-89-4) at 4°C, (iii) washed thrice with PBS, (iv) permeabilized for 10 min with 0.3% Triton X-100 in PBS, (v) washed thrice with PBS, and (vi) blocked for 1 h with 2% NGS in PBS at RT. After blocking, immunohistochemistry of both paraffin-and cryo-sections was performed similarly by (i) incubation of the slices with specific primary antibody diluted in 2% NGS overnight at 4°C, (ii) three washes with PBS, (iii) incubation with secondary antibody for 30 min in the dark at RT, (iv) three washes with PBS, (v) counterstaining with 4′,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, CAS # 28718-90-3), (vi) two washes with PBS, (vii) embedding with Mowiol mounting medium (Sigma-Aldrich, CAS # 9002-89-5), and (viii) analyzed using an AxioImager M1 microscope with AxioCam MRm monochrome and AxioCam MRc color cameras (Carl Zeiss AG, Oberkochen, Germany) and a Zeiss CLSM 710 spectral confocal laser scanning microscope. Images were processed using AxioVision 4.8.2 (Carl Zeiss AG, Oberkochen, Germany) and Imaris 8.2 (Bitplane Inc.) software. Immunohistochemistry of whole mount embryos was done as described previously (Joyner and Wall, 2008) .
Primary antibodies used were: rabbit anti-HCF-1 (1:1000, H12, (Wilson et al., 1993) ), rat anti-Ki67 (1:60, eBioscience cat. # 41-5698), anti-HNF4α (1:100, R&D Systems cat. # PP-H1415-00) and anti-PCNA (1:50, BD Transduction Laboratories cat. # 610665) mouse monoclonal antibodies, rabbit anti-Histone H3 phospho Ser10 (1:100, Abcam cat. # ab5176), rabbit anti-Oct4 (1:250, Abcam cat. # ab19857), and chicken anti-GFP (1:500, Aves Labs, Inc. cat. # GFP-1020).
Secondary antibodies used were: goat anti-rabbit Alexa 488 (1:400, Molecular Probes cat. # A11034), goat anti-mouse Alexa 568 (1:500, Molecular Probes cat. # A11019), goat anti-rabbit Alexa 568 (1:1000, Molecular Probes cat. # A21069), goat anti-mouse Alexa 488 (1:400, Molecular Probes cat. # A11029), donkey antimouse Alexa 594 (1:500, Molecular Probes cat. # A11005), and goat anti-mouse Alexa 635 (1:300, Molecular Probes cat. # A31575).
TUNEL assay
Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) was performed on paraffin-embedded embryo sections with the in situ cell death detection kit (Roche Applied Science, product # 11684795910), according to the manufacturer directions.
Partial hepatectomy
2/3 or 70% partial hepatectomy (PH) was performed as described (Mitchell and Willenbring, 2008) .
Measurement of body composition by EchoMRI
Total body fat, lean mass, free liquids, and total body water of live mice were measured with EchoMRI™-100H body composition analyzer under isoflurane anesthesia.
Quantitation and statistical analyses
For Supplemental Tables 1 and 3, cells in the entire embryonic region of single 4 mm-thick paraffin sections were counted. For Supplemental Table 4 , for each liver studied, all cells in a representative field of a 4 mm-thick paraffin section were counted.
Both χ 2 tests and Student's t-tests were performed by using the R package (www.r-project.org).
Results
Generation of the Hcfc1
cKO allele Fig. 1A shows a schematic of the wild-type mouse HCF-1 protein (a), and a description of the genesis of the cKO Hcfc1 cKO allele (b-d) along with its hypothetical truncated HCF-1 product (e). The mouse Hcfc1 gene consists of 26 exons spread over 25 kb ( Fig. 1Ab ; Kristie, 1997) . We designed and obtained (see Section 2) a C57BL/6 Hcfc1 allele, called Hcfc1 lox , with individual loxP sites flanking exons 2 and 3 (Fig. 1Ac) for Cre recombinase-mediated exon2/3 deletion generating the Hcfc1 cKO allele (Fig. 1Ad) . Pre-mRNA splicing of the remaining Hcfc1 cKO exons 1 and 4 (see Section 2)
generates an mRNA in which the reading frame goes out of frame for 2 codons (encoding Gly-Thr) before encountering a termination codon (Fig. 1Ae) 
Broad Hcfc1 expression in mouse tissues
Before analyzing the effects of Hcfc1 inactivation, we assayed Hcfc1 expression in the mouse. The human HCFC1 gene is highly expressed in actively dividing cells in culture and in fetal and placental tissues (Wilson et al., 1995) ; it continues to be expressed in adult tissues, comprising mostly quiescent cells, though the levels are comparatively reduced (Huang et al., 2012; Wilson et al., 1995) . Here, we investigated the levels and subcellular localization of mouse HCF-1 by immunostaining wt and Hcfc1 lox/Y male embryos and postnatal tissues. HCF-1 was ubiquitous and predominantly nuclear in (i) Hcfc1 lox/Y embryonic day (E) 2.5 and that, when paternally inherited, directs an onset of Cre recombinase synthesis around E4.5 exclusively in the post-implantation epiblast (Hayashi et al., 2002 (Hayashi et al., , 2003 .
A cross between Hcfc1 E5.5, giving time for depletion of HCF-1 in the majority of epiblast cells by E5.5. As shown in Fig. 4B ). Thus, epiblast-specific loss of Hcfc1 function in males results in an embryonic lethality between E5.5 (see Fig. 2A ) and E9.5 -this lethality is not explored further here. In contrast to the male offspring, female offspring listed in Table 2 Fig. 5 ), remained healthy beyond 1 year and were fertile.
A maternally inherited Hcfc1
XmKO allele is lethal
We used the fertile Sox2Cre tg ; Hcfc1 epiKO/ þ females to study the requirements for HCF-1 function early in development, taking advantage of the differential activation/inactivation of the maternal Xm and paternal Xp inherited X-chromosomes post fertilization (see Section 1). Table 2 for a description of the Hcfc1 allele outcomes of Crosses 1 and 2). Indeed, it cannot as the only normal embryos or pups obtained in this cross were either Hcfc1 þ /Y males or Hcfc1 þ / þ females (Table 3, columns 1 and 3; p-value 6.7 Â 10 À 8 ). Given the Hcfc1 epiKO/Y lethality described in Table 2 , the absence of Hcfc1 XmKO/Y male embryos or pups lacking a wild-type Hcfc1 þ allele was to be expected (column 2). Here, however, whereas heterozygous Hcfc1 epiKO/ þ embryos and pups were viable in Table 2 , a Sites of resorption.
Table 3
The Hcfc1 KO allele is lethal when transmitted through the maternally inherited X M chromosome but not when generated de novo on the paternally inherited X P chromosome upon fertilization.
heterozygous Hcfc1 XmKO/ þ pups were non-existent and embryos were highly abnormal (column 4; see below). These results indicate that the maternal Xm Hcfc1 þ allele is required in extraembryonic tissue and/or before the epiblast stage of embryonic development.
To explore the nature of the lethality generated by the maternal Hcfc1
XmKO allele, we immunostained paraffin sections of embryos obtained from Cross 1 at E7.5 as shown in Fig. 3 . For this analysis, we used Oct4 immunofluorescence to distinguish embryonic (Oct4 positive) and extraembryonic (Oct4-negative) tissues (Fig. 3A) . Wild-type embryos (Table 3 , columns 1 and 3) revealed HCF-1 staining in both embryonic and extraembryonic (visceral endoderm) tissues (Fig. 3A-D, top panels) . In wild-type embryos there was also marked staining for the broad cell-proliferation marker Ki67 (Scholzen and Gerdes, 2000) (Fig. 3B ) and the interphase and mitotic marker histone H3 phosphorylated at serine 10 (H3S10P) (Prigent and Dimitrov, 2003) (Fig. 3C) , thus displaying an active proliferation phenotype. Furthermore, TUNEL assays revealed little apoptosis (Fig. 3D) . In contrast, the highly abnormal Hcfc1 XmKO/ þ female embryos (Table 3 , column 4), with Xm Hcfc1 XmKO and Xp Hcfc1 þ alleles, were significantly smaller in size (Fig. 3A-D) than their wild-type littermate embryos. Consistent with maternal Hcfc1 XmKO inheritance, HCF-1 immunostaining revealed an absence of HCF-1 in the extraembryonic region (Fig. 3A-D) . The cells in the abnormal epiblast region (i.e., Oct4 positive; Fig. 3A bottom panel) , however, were essentially all HCF-1 positive (Fig. 3A-D) , which must be owing to an active wild-type paternal Xp Hcfc1 þ allele.
Nevertheless, although HCF-1 positive, these abnormal embryos displayed a significant reduction in Ki67 and H3S10P labeling and a high proportion of apoptotic cells when compared to control embryos ( Fig. 3B-D) . These results are most easily explained if HCF-1 function is essential for proper extraembryonic development and that thus, in its absence, the extraembryonic tissue cannot support proper embryonic development.
3.5. An Hcfc1 cKO allele on the paternally inherited X in Hcfc1
heterozygotes is viable
Cross 2 tests the phenotype of Hcfc1 inactivation on the paternally inherited Xp chromosome at the onset of development. The outcome of Cross 2 (Sox2Cre
influenced by the presence of the Sox2Cre tg allele in the mothers, because the Sox2Cre tg allele is expressed in the female germ-line and the Cre recombinase enzyme thus synthesized in the oocyte is maternally inherited in the zygote irrespective of the segregation of the autosomal Sox2Cre transgene (Hayashi et al., 2003; Vincent and Robertson, 2003) . Such maternally inherited Cre recombinase will result in efficient loxP-site induced recombination throughout the embryonic and extraembryonic derivatives of the early embryo (Hayashi et al., 2003; Vincent and Robertson, 2003) . Thus, in this cross, the Xp Hcfc1 lox allele is expected to undergo efficient cKO deletion following fertilization. Consistent with this expectation, in this cross, the Hcfc1 Xplox allele did not survive irrespective of whether the Sox2Cre tg transgene was inherited or not, indicating that the loxP to cKO conversion was 100% efficient and thus readily supported by the maternally inherited Cre enzyme. Interestingly, although as expected from the results of Cross 1 described above we did not obtain male or female embryos with the maternally inherited Hcfc1
XmKO allele (Table 3 , columns 2 and 6; p-value 2.3 Â 10 À 9 ), we did obtain, albeit in somewhat lower numbers, normal female embryos and pups carrying the paternally inherited Hcfc1 XpKO allele (column 5, p-value relative to wildtype Hcfc1 þ /Y ¼ 0.15). As shown in Fig. 4 , however, the E7.5 embryos were smaller, indicating a transitory developmental retardation (see also below). Comparative HCF-1 immunostaining of littermate wild-type and heterozygous Hcfc1 þ /XpKO female embryos at E7.5 revealed HCF-1 throughout the embryonic and extraembryonic tissue (Fig. 4) . Additionally, labeling for Ki67 and H3S10P ( Fig. 4B and C) demonstrated active proliferation and TUNEL staining (Fig. 4D) effects on extraembryonic development have been observed previously for essential X-linked genes (Longo et al., 2002; O'Donnell et al., 2004) . Because an Hcfc1 cKO allele could not be transmitted through the male nor female germ line, this Hcfc1 cKO allele cannot be maintained by germ-line transmission.
3.6. Hcfc1 epiKO allele initially resides on the female active or inactive X As aforementioned (see Fig. 1C and To address this question, as shown in Fig. 5A , we immunostained paraffin sections of Sox2Cre tg ; Hcfc1 epiKO/ þ embryos at E5.5 at which point we know from their male siblings (Fig. 2 ) that they will have undergone Cre recombinase-induced Hcfc1 epiKO -allele conversion. In these embryos, the epiblast was a mixture of 60-65% HCF-1-positive and 35-40% HCF-1-negative nuclei ( Fig. 5A and E ; arrows indicate HCF-1-negative nuclei). The number of HCF-1-negative nuclei was twofold higher in male E5.5 hemizygous Hcfc1 epiKO/Y embryos (65-70%; Fig. 2 ) than in the female Hcfc1 epiKO/ þ embryos (35-40%); this result can be explained if there is little to no a priori skewing of X-chromosome inactivation such that roughly half the epiblast cells carry either the wild-type Hcfc1 þ or mutant Hcfc1 epiKO allele on the active X chromosome. This result is consistent with (i) effective Hcfc1 epiKO allele generation at around E4.5 to E5.5 ( Fig. 2 ; Hayashi et al., 2002) , (ii) X-chromosome inactivation during the same period (Mak et al., 2004; McMahon et al., 1983; Rastan, 1982) , and (iii) relatively rapid depletion by HCF-1 turnover or dilution in proliferating cells.
HCF-1-positive cells compensate for and replace HCF-1-negative cells during Hcfc1 epiKO/ þ female embryonic development
The embryonic lethality of Hcfc1 epiKO/Y males (Table 2) suggests that heterozygous Hcfc1 epiKO/ þ female embryos that represent a mixture of HCF-1-positive and -negative cells (Fig. 5A ) survive because cells positive for HCF-1 are able to compensate for those that are negative for HCF-1. Such compensation could be non-cell autonomous such that late stage embryos or adults possess both HCF-1-positive and -negative cells. Alternatively, Hcfc1 function could be required cell autonomously in which case HCF-1-positive cells must somehow replace HCF-1-negative cells. For example, Hcfc1 function may be required in specific tissues and only HCF-1-positive cells populate those tissues; alternatively Hcfc1 function may be universally required such that HCF-1-negative cells completely disappear.
To discriminate among these possibilities, we assayed the presence and absence of HCF-1-positive and -negative cells past E5.5. Fig. 5 shows the results of the analysis of stages E6.5 (Fig. 5B) , E7.5 (Fig. 5C) , and E8.5 (Fig. 5D) , with quantitation shown in Fig. 5E for E5.5 through E7.5. Indeed, from E6.5 to E7.5, HCF-1-negative cells continued to persist (Fig. 5B and C, see white arrows) but The boxed regions at E5.5, E6.5, E7.5, and E8.5 are shown at higher magnification in subsequent panels. The arrows indicate HCF-1-negative DAPI-stained nuclei.
(E) Percentage of HCF-1-negative cells from E5.5 to E7.5 (n¼ 3 for E5.5, n ¼8 for E6.5, and n¼ 8 for E7.5). (*p-value o0.05, ***p-value o 0.001). Scale bar: 50 μm.
their levels progressively decreased to approximately 25% (E6.5) and 10% (E7.5) of the total embryonic cells (Fig. 5E ), such that by E8.5 HCF-1-negative cells had essentially disappeared (Fig. 5D , see arrow) to a single evident HCF-1-negative cell. These results suggest that HCF-1 function is essential and cell autonomous, such that HCF-1-positive cells broadly and progressively replace and compensate for HCF-1-negative cells during a period of embryogenesis that encompasses gastrulation, a process key in the initiation of tissue differentiation.
The observed mixed population of HCF-1-positive and -negative cells early in embryogenesis followed by an eventual dominance of HCF-1-positive cells later in embryogenesis is most easily explained if cells carrying the Hcfc1 þ allele on the active X chromosome are positively selected during Hcfc1 epiKO/ þ embryogenesis. To address this hypothesis directly, we employed an X chromosome marked with a green fluorescent protein transgene called XGFP (Hadjantonakis et al., 2001 (Hadjantonakis et al., , 1998 The results of this experiment are shown in Fig. 6 , with GFP levels analyzed by whole-mount GFP immunostaining. As expected, the Hcfc1 lox/Y male embryos did not display specific GFP staining at any stage (Fig. 6A, D, and G) . In contrast, both E6.5 Hcfc1 lox/ þ and Hcfc1 epiKO/ þ XGFP tg embryos displayed a mottled GFP staining pattern (Fig. 6B and C) consistent with random inactivation of the XGFP tg chromosome. In concordance with the disappearance of HCF-1-negative cells in Hcfc1 epiKO/ þ embryos, over the next two days of development, the percentage of GFPpositive cells (carrying the active wild-type Hcf1 þ allele) increased such that, throughout the entire embryo, we failed to observe tissues with GFP-negative cells (compare Fig. 6E and F, and H and I). We also similarly assayed GFP -as well as HCF-1 -levels in the eye later in embryonic development (i.e., E14.5; Supplemental Fig. 6 ) and in early postnatal (P5) brain and liver (Supplemental Fig. 7 ) and similarly observed a broad, essentially universal, presence of GFP and HCF-1 in the Hcfc1 epiKO/ þ ; XGFP tg but not
These results suggest an early universal strong selection for the Hcfc1 þ allele on the active X chromosome (i.e., HCF-1-positive cells) leading to 100% selection of cells carrying the Hcfc1 epiKO -allele on the inactive X-chromosome -a so-called complete secondary skewing of X-chromosome inactivation. This skewing by which HCF-1-positive cells compensate for HCF-1-negative cells is apparently effective: although Hcfc1 epiKO/ þ embryos are reduced in size and developmentally retarded between E6.5 and at least E8.5 (Supplemental Fig. 8A -C) -owing to an apparent subsequent acceleration in development and growththis reduction is largely transient as, for example, E9.5 (Supplemental Fig. 4B ) and E14.5 (Supplemental Fig. 8D ) Hcfc1 lox/ þ and Hcfc1 epiKO/ þ embryos are of similar size. Combined with the high frequency of Hcfc1 epiKO/ þ heterozygous pup births (Table 2) 
HCF-1-negative cells proliferate in E6.5 embryos
Hcfc1 is implicated in cell proliferation Julien and Herr, 2003) . Thus, the presence in Fig. 5 of large numbers of HCF-1-negative cells in E6.5 embryos one to two days after Hcfc1 lox to Hcfc1 epiKO conversion was surprising. We hypothesized that at E6.5 after Hcfc1 lox to Hcfc1 epiKO conversion HCF-1-negative embryonic cells might still proliferate. To test this hypothesis we co-stained E6.5 Hcfc1 epiKO/ þ embryos for HCF-1 and three cellcycle markers: Ki67, the S-phase marker BrdU, and H3S10P. As shown in Fig. 7 and quantitated in Fig. 9A (see also Supplemental Table 3 ), E6.5 HCF-1-negative cells (white arrows) are frequently positive for Ki67 (Fig. 7A ), BrdU incorporation (Fig. 7B) , and H3S10P (Fig. 7C) , indicating that indeed HCF-1-negative cells continue to proliferate. Nevertheless, eventually the HCF-1-negative cells disappear. Consistent with this observation, (i) at E7.5 we observe many HCF-1-negative -but not HCF-1-positive -cells missing the Ki67 cellproliferation marker (Figs. 8A and 9B) , and (ii), as evidenced by TUNEL assays (Figs. 7D and 8B and quantitated in Fig. 9 ), E6.5 and E7.5 HCF-1-negative -but not HCF-1-positive -cells undergo apoptosis. Thus continued proliferation of HCF-1-negative cells appears to lead to cell-cycle exit and eventual apoptosis and disappearance.
HCF-1 is crucial for proliferation during liver regeneration
The requirement for HCF-1 in mammalian cell proliferation has been established in tissue culture cells, but not in an in vivo physiological context. The continued proliferation of HCF-1-deficient cells observed here during early embryogenesis does not reveal an immediate essential HCF-1 function in embryonic cell proliferation. We thus also addressed a role for HCF-1 in cell proliferation in a non-embryonic context, by taking advantage of the high regenerative potential of the mammalian liver. After twothirds partial hepatectomy (PH), remaining resting hepatocytes rapidly and synchronously re-enter the cell-division cycle to regenerate the liver mass within one to two weeks (Fausto et al., 2006; Michalopoulos and DeFrances, 1997; Taub, 2004) . We utilized this regenerative ability of the liver to study HCF-1 function in de novo cell-proliferation entry and progression by resting cells.
For this purpose, we induced hepatocyte-specific deletion of the Hcfc1 lox allele (called Hcfc1 hepKO , see Table 1 ) by tamoxifen activation of an Albumin-Cre (Alb-Cre-ERT2 tg ) allele (Schuler et al., 2004) Fig. 10B ) and -negative (mauve arrows) cells, respectively -are positive for HCF-1 (Fig. 10A and B Fig. 10C and D) , whereas smaller HNF4α-negative non-hepatocyte liver cell types remain HCF-1 positive (mauve arrow, Fig. 10D ), patches of HNF4α-positive hepatocytes either HCF-1-positive (green arrow, Fig. 10D ) or HCF-1-negative (white arrow and dashed line ovals, Fig. 10D ) appear. The HCF-1-negative clusters ; n¼ 5) and TUNEL (p-value 7 Â 10 À 4 ; n¼ 6) were highly significant. 
Hcfc1
lox/ þ mice, we performed PH and analyzed the liver tissue 48 h later -at which point hepatocytes are actively passing through the cell-division cycle -for (i) Ki-67 (Fig. 11B ), (ii) the S-phase marker Proliferating Cell Nuclear Antigen (PCNA) (Fig. 11D) , which displays evident S-phase nuclear staining (Kelman, 1997) , and (iii) H3S10P (Fig. 11F) . Prior to PH, few if any tamoxifen-induced Hcfc1 hepKO/ þ hepatocytes were positive for any of these three cell-proliferation makers (Fig. 11A, C , and E); 48 h post-PH, however, many cells were positive for these three markers (Fig. 11B , D, and F) but only in the patches of HCF-1-positive hepatocytes (green arrows) -hepatocytes lacking HCF-1 (white arrows) were negative for the three cell cycle markers (see also Supplemental Fig. 10 ), indicating that HCF-1 is required for proper hepatocyte proliferation during liver regeneration and thus important for cell-cycle re-entry by these resting cells. Quantitative analysis of the results shown in Fig. 12 (see also Supplemental Table 4 ) reinforces this conclusion. 
Discussion
We have generated a silent allele of the mouse Hcfc1 gene, called Hcfc1 lox , that can be conditionally deleted with Cre recombinase. We take advantage of the broad expression and X-chromosome linkage of the Hcfc1 gene to study its role in embryonic and extraembryonic development, and adult tissue regeneration. An unexpected by-product of the X chromosome linkage of the Hcfc1 gene and the cell-autonomous requirement for HCF-1 in early embryonic-cell viability is the ability to genetically address the sensitivity of the early post-implantation embryo to major cell loss.
HCF-1 has extensive roles in cell proliferation
Our studies show that HCF-1 is important for both embryonic and extraembryonic mammalian development and illuminate its role in cell proliferation in two very different contexts: the post-implantation embryo and the adult regenerating liver. Significantly, these two contexts differ in the status of the cells in which HCF-1 is being depleted -in the embryonic cells HCF-1 is being depleted in proliferating cells whereas in the adult liver HCF-1 is being depleted in resting cells -and the effects differ. In the embryonic cells, although eventually having an effect, depletion of HCF-1 does not have an apparent immediate cell-proliferation arrest effect. This phenotype is reminiscent of the temperature-sensitive tsBN67 hamster cell line, in which cells continue to proliferate after shift to the non-permissive temperature .
In the case of the Hcfc1 epiKO/ þ embryos, the delay in loss of HCF-1-negative cells may be owing to a period post Hcfc1 epiKO induction in which, as examples, (i) it takes time for levels of HCF-1 (an abundant and stable protein; (Wilson et al., 1995; Wysocka et al., 2001) ) to fall below the amount necessary to support cell proliferation (a level not being easily detected by our immunofluorescence analyses), (ii) loss of HCF-1 transcriptional regulatory function does not have an immediate effect on transcription of its regulatory targets (e.g., it could activate histone modifications that are maintained for some cell generations via an HCF-1-independent mechanism), or (iii) HCF-1 is not required for cell proliferation at the time of epiblast-specific inactivation. Vis-à-vis the latter example, the ability of E6.5 HCF-1-negative cells to proliferate may be related to the rapid proliferation status of these cells where negative regulators of the cell-division cycle such as the pRb-related pocket protein family are apparently inactive (reviewed in Ciemerych and Sicinski (2005) ). Indeed, inhibition of pRb-related pocket protein family function can suppress the need for HCF-1 function in cell proliferation ) -E6.5 cells may represent such cells with suppressed pRb-related pocket protein family function.
In contrast, the essentially complete sensitivity of hepatocyte proliferation to HCF-1 depletion upon PH-induced liver regeneration may be explained by the fact that, in the liver regeneration protocol, it is possible to deplete resting hepatocytes over seven days before challenging them to proliferate de novo and HCF-1 is essential for de novo hepatocyte proliferation where the pRb-related pocket protein family is likely active.
HCF-1 plays early roles in embryonic cell proliferation
The generation of the epiblast-specific Hcfc1 epiKO allele with the Sox2Cre transgene permits the study of HCF-1 function at an early stage of embryonic development -around E5.5 and beyond. Furthermore, as shown in Table 3 , we did not observe any embryos that would have lacked HCF-1 from conception (i.e., Hcfc1
XmKO/Y and Hcfc1 XmKO/XpKO embryos), suggesting that HCF-1 plays a role in cell proliferation even before implantation. Consistent with this hypothesis, HCF-1 plays a positive role in embryonic stem-cell proliferation (Dejosez et al., 2010) . Even if only required after E7.5, few cell proliferation genes are required so early in development (Ciemerych and Sicinski, 2005) . This very early requirement for Hcfc1 function could be because in vertebrates it is a member of a small gene family consisting of only two genes -Hcfc1 and the much smaller HCF-2-encoding Hcfc2 (Johnson et al., 1999) gene -such that there is little possibility for redundant gene functions. Additionally, HCF-1 associates with large numbers of transcriptional start sites in both embryonic-stem cells (743) and transformed HeLa cells (5400) (Dejosez et al., 2010; Michaud et al., 2013) . Such potentially broad involvement in transcriptional regulation could explain an early essential role for HCF-1 in embryogenesis.
4.3. Development of the mouse post-implantation embryo is highly resistant to cell loss Animal development involves cell proliferation in which cells become increasingly committed to particular developmental or differentiation pathways. The timing of such commitment and its sensitivity to perturbation varies among species. For example, in the deterministic development of the Caenorhabditis elegans worm embryo, differentiation commitment occurs during the first cell divisions and embryonic development is exquisitely sensitive to individual cell loss (Sulston et al., 1983) . By contrast, early mammalian embryonic development is much less deterministic and ), (B) PCNA (n¼ 4 prePH; n¼ 3 postPH) (p-value 6.6. Â 10 À 3 ), and (C) H3S10P (n¼ 4 prePH; n ¼4 postPH) (p-value 9.0 Â 10 À 4 ) in sections of Alb-Cre-ERT2 tg ; Hcfc1 hepKO/ þ heterozygous female mice 7 days post-tamoxifen treatment before (prePH) and 48 h after (postPH) being subjected to 70% PH.
there is considerable plasticity in cell differentiation commitment, particularly prior to implantation (Martinez Arias et al., 2013) . For example, embryonic cell-depletion experiments pre-implantation -either micromanipulation to remove one or two cells from twoto-four cell embryos (Power and Tam, 1993; Rands, 1986) or pharmacological intervention of 16-32 cell morula-stage embryos (Tam, 1988 ) -have shown eventual normal development post cell depletion. Post-implantation, however -for example, during gastrulation which occurs at E6.5 to E7.5 -there is a rapid determination of cell differentiation pathways (e.g., the three germ layers). This progressive determination means that, as development progresses, cells will have followed a greater number of differentiation pathways and functional replacement to compensate for cell loss may become more difficult. Nevertheless, one study has shown that treatment of embryos at E6.5 to E7.0 with the cytotoxic drug mitomycin C can lead to a rapid 85% reduction in cell number and, in response, to an accelerated cell proliferation response, such that embryos recover in size and developmental stage by approximately E10.5 (Snow and Tam, 1979) .
Here, by virtue of (i) an early embryonic cell-proliferation requirement for HCF-1 function, (ii) the X-chromosome linkage of the Hcfc1 gene, and (iii) the creation of a Cre-inducible cKO Hcfc1 lox allele, we have probed through genetic manipulation, rather than pharmacological intervention, the resistance of the postimplantation mouse embryo to progressive cell loss beginning before and ending after gastrulation. In this case, although the lethality of Hcfc1 epiKO/Y male embryos would suggest otherwise, the progressive loss of HCF-1-negative cells in Hcfc1 epiKO/ þ female heterozygotes may be owing to cell competition, whereby HCF-1-negative cells are not inherently unable to proliferate but instead they are out-competed by the HCF-1-positive cells. Whether by a competitive or a non-competitive mechanism, this genetically engineered post-implantation loss of HCF-1-negative cells had little effect on developmental success even as the embryos underwent gastrulation, a critical phase of development. In this case, survival may be aided by the extensive salt and pepper pattern of HCF-1 loss such that all parts of the embryo have plenty of HCF-1-positive cells with which to compensate for cells lacking HCF-1. Whatever the case, our results show that mammalian embryonic plasticity permits the survival of female embryos heterozygous for an X-linked embryonic lethal allele.
